Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Primary Sclerosing Cholangitis
NCT01142323Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Oct 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fenofibrate in Primary Sclerosing Cholangitis (PSC), sponsored by University of Miami. Primary endpoint: Serum Alkaline Phosphatase at 6 months. Started Oct 2010; status: terminated.
02
Drugs
fenofibrate
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT01142323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142323.